Modulation of Antioxidant Enzyme Expression and Function by Estrogen
暂无分享,去创建一个
G. Nickenig | C. Grohé | M. Böhm | S. Wassmann | O. Adam | K. Strehlow | K. Laufs | S. Rotter
[1] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[2] Deborah Grady,et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.
[3] R. Karas,et al. The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.
[4] R. Behl,et al. FSH induced stimulation of catalase activity in goat granulosa cells in vitro. , 2002, Animal reproduction science.
[5] H. Brown-Borg,et al. Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Hepatocyte Antioxidative Enzymes , 2002, Experimental biology and medicine.
[6] M. Boegehold,et al. Effect of a High Salt Diet on Microvascular Antioxidant Enzymes , 2002, Journal of Vascular Research.
[7] M. Hung,et al. Akt activation by estrogen in estrogen receptor-negative breast cancer cells. , 2001, Cancer research.
[8] Y. Katagiri,et al. Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. , 2001, Atherosclerosis.
[9] W. Aird,et al. Vascular endothelial growth factor induces manganese‐superoxide dismutase expression in endothelial cells by a Racl‐regulated NADPH oxidase‐dependent mechanism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] J. Cauley,et al. Effect of Estrogen plus Progestin on Risk for Biliary Tract Surgery in Postmenopausal Women with Coronary Artery Disease: The Heart and Estrogen/progestin Replacement Study , 2001, Annals of Internal Medicine.
[11] M. Hecker,et al. 17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells , 2001 .
[12] V. Muzykantov. Targeting of superoxide dismutase and catalase to vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[13] H. Drexler,et al. Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase , 2001, Circulation.
[14] G. Nickenig,et al. Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats , 2001, Circulation.
[15] G. Nickenig,et al. Differential Effects of Estrogen and Progesterone on AT1 Receptor Gene Expression in Vascular Smooth Muscle Cells , 2000, Circulation.
[16] K. Irani. Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. , 2000, Circulation research.
[17] H. Jo,et al. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. , 2000, Free radical biology & medicine.
[18] G. Kojda,et al. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. , 2000, The Journal of clinical investigation.
[19] H. Drexler,et al. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. , 2000, Circulation.
[20] J. Pfeilschifter,et al. Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. , 2000, The Biochemical journal.
[21] F. Sánchez-Jiménez,et al. Role of reactive oxygen species in apoptosis: implications for cancer therapy. , 2000, The international journal of biochemistry & cell biology.
[22] R. Nagai,et al. Inducible expression of manganese superoxide dismutase by phorbol 12-myristate 13-acetate is mediated by Sp1 in endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[23] J. Matés,et al. Antioxidant enzymes and human diseases. , 1999, Clinical biochemistry.
[24] L. Ji,et al. Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[25] B. Berk. Redox Signals that Regulate the Vascular Response to Injury , 1999, Thrombosis and Haemostasis.
[26] D. Harrison,et al. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. , 1999, Circulation research.
[27] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[28] C. Thiemermann,et al. Identification of copper/zinc superoxide dismutase as a novel nitric oxide‐regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] G. Gibori,et al. Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase in the rat corpus luteum: induction of manganese superoxide dismutase messenger ribonucleic acid by inflammatory cytokines. , 1998, Biology of reproduction.
[30] S. Rosenkranz,et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. , 1998, Circulation.
[31] D. Harrison,et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. , 1998, The Journal of clinical investigation.
[32] G. Garcı́a-Cardeña,et al. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. , 1997, Circulation research.
[33] J. Crapo,et al. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[34] D. Harrison. Endothelial Function and Oxidant Stress , 1997, Clinical cardiology.
[35] C. Rosenfeld,et al. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. , 1997, The American journal of physiology.
[36] R. Vogel. Coronary risk factors, endothelial function, and atherosclerosis: A review , 1997, Clinical cardiology.
[37] T. Oury,et al. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[38] A. Nègre-Salvayre,et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[39] N. Wenger,et al. Cardiovascular health and disease in women. , 1993, The New England journal of medicine.
[40] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[41] S. Marklund. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. , 1992, The Journal of biological chemistry.
[42] M. Hong,et al. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. , 1992, The American journal of cardiology.
[43] P. Poole‐Wilson,et al. Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro , 1991, British journal of pharmacology.
[44] L. Oberley,et al. An assay for superoxide dismutase activity in mammalian tissue homogenates. , 1989, Analytical biochemistry.
[45] N. Sugino,et al. Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone withdrawal in human endometrial stromal cells. , 2002, Molecular human reproduction.
[46] M. Dieudonné,et al. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. , 2002, Endocrinology.
[47] J. Keaney,et al. Redox control of vascular nitric oxide bioavailability. , 2000, Antioxidants & redox signaling.
[48] H. Jo,et al. Nitric oxide, free radicals and cell signalling in cardiovascular disease. , 1997, Biochemical Society transactions.
[49] A. Whittemore,et al. Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.